Review Test Submission: Week 11 Final Exam
Examination Study Guide 2022
Course NURS-6630D-3/NURS-6630N-3/NURS-6630F-3-Approaches to Treatment2018 Fall
Quarter 08/27-11/18-PT27
Test Week 11 Final Exam
Started 11/10/18 1:37 PM
Submitted 11/10/18 3:01 PM
Due Date 11/12/18 1:59 AM
Status Completed
Attempt Score 72 out of 75 points
Time Elapsed 1 hour, 24 minutes out of 2 hours
Results Submitted Answers
Displayed
• Question 1
1 out of 1 points
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs to
manage the top-down cortical control and the excessive drive from striatal hyperactivity?
Selected Answer: C.
Antipsychotics
• Question 2
1 out of 1 points
The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic
behaviors with poor impulse control and aggression. Of the available treatments, which can help
temper some of the adverse effects or symptoms that are normally caused by D2 antagonism?
Selected Answer: D.
Second-generation, atypical antipsychotics
, Review Test Submission: Week 11 Final Exam
Examination Study Guide 2022
• Question 3
1 out of 1 points
The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive
behaviors in patients with the student. Why does the PMHNP prescribe a standard dose of atypical
antipsychotics?
Selected Answer: C.
The doses are based on achieving 60% D2 receptor occupancy.
• Question 4
1 out of 1 points
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the patient
with psychosis and aggression?
Selected Answer: A.
There is too high a risk of serious adverse side effects.
• Question 5
1 out of 1 points
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the PMHNP
exhibits proper care for this patient? </p?
Selected Answer: C.
Titrating the dose by increasing it every 5–7 days
• Question 6
1 out of 1 points
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and impulsive
symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer will the PMHNP
select?
, Review Test Submission: Week 11 Final Exam
Examination Study Guide 2022
Selected Answer: A.
Lithium (Lithane)
• Question 7
1 out of 1 points
The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on their
child. The parents prefer to start pharmacological treatment with a non-stimulant. Which medication
will the PMHNP will most likely prescribe?
Selected Answer: A.
Strattera
• Question 8
1 out of 1 points
The PMHNP understands that slow-dose extended release stimulants are most appropriate for which
patient with ADHD?
Selected Answer: A.
8-year-old patient
• Question 9
1 out of 1 points
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the
PMHNP include when discussing the side effects with the patient?
Selected Answer: C.
The medication can affect your blood pressure.
• Question 10
1 out of 1 points
Examination Study Guide 2022
Course NURS-6630D-3/NURS-6630N-3/NURS-6630F-3-Approaches to Treatment2018 Fall
Quarter 08/27-11/18-PT27
Test Week 11 Final Exam
Started 11/10/18 1:37 PM
Submitted 11/10/18 3:01 PM
Due Date 11/12/18 1:59 AM
Status Completed
Attempt Score 72 out of 75 points
Time Elapsed 1 hour, 24 minutes out of 2 hours
Results Submitted Answers
Displayed
• Question 1
1 out of 1 points
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs to
manage the top-down cortical control and the excessive drive from striatal hyperactivity?
Selected Answer: C.
Antipsychotics
• Question 2
1 out of 1 points
The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic
behaviors with poor impulse control and aggression. Of the available treatments, which can help
temper some of the adverse effects or symptoms that are normally caused by D2 antagonism?
Selected Answer: D.
Second-generation, atypical antipsychotics
, Review Test Submission: Week 11 Final Exam
Examination Study Guide 2022
• Question 3
1 out of 1 points
The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive
behaviors in patients with the student. Why does the PMHNP prescribe a standard dose of atypical
antipsychotics?
Selected Answer: C.
The doses are based on achieving 60% D2 receptor occupancy.
• Question 4
1 out of 1 points
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the patient
with psychosis and aggression?
Selected Answer: A.
There is too high a risk of serious adverse side effects.
• Question 5
1 out of 1 points
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the PMHNP
exhibits proper care for this patient? </p?
Selected Answer: C.
Titrating the dose by increasing it every 5–7 days
• Question 6
1 out of 1 points
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and impulsive
symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer will the PMHNP
select?
, Review Test Submission: Week 11 Final Exam
Examination Study Guide 2022
Selected Answer: A.
Lithium (Lithane)
• Question 7
1 out of 1 points
The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on their
child. The parents prefer to start pharmacological treatment with a non-stimulant. Which medication
will the PMHNP will most likely prescribe?
Selected Answer: A.
Strattera
• Question 8
1 out of 1 points
The PMHNP understands that slow-dose extended release stimulants are most appropriate for which
patient with ADHD?
Selected Answer: A.
8-year-old patient
• Question 9
1 out of 1 points
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the
PMHNP include when discussing the side effects with the patient?
Selected Answer: C.
The medication can affect your blood pressure.
• Question 10
1 out of 1 points
